EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Effectiveness of Opioids and Opioid Substitutes on Pain and Health Related Quality of Life Among Cancer Survivors

Shirley K Chan Sanchez iD, Samuel V David iD, Efstathia Polychronopoulou iD, Mukaila Raji iD, Yong-Fang Kuo iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.71189 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Medicine, 2025. Verfasst von Shirley K Chan Sanchez und 4 weiteren Autor:innen. Beteiligte Einrichtung: John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Quality of Life, Analgesics, Opioid, Cancer Survivors, Cancer Pain. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, Cancer Prevention and Research Institute of Texas, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic pain is a major but modifiable contributor to poor quality of life among long‐term cancer survivors. With growing concern over opioid‐related risks, gabapentinoids have emerged as a safer alternative, though evidence comparing their effectiveness remains limited.

Methods

We conducted a retrospective cohort study using SEER‐MHOS linked data (1998–2021) to examine pain interference and health‐related quality of life (HRQoL) among 24,651 cancer survivors. Participants were categorized as opioid‐only (OPIOID‐only), gabapentinoid‐only (GABA‐only), both (BOTH), or no medication (NONE). Changes in pain interference and Physical and Mental Component Summary scores (PCS, MCS) were analyzed using paired t‐tests and multivariate regression, adjusting for demographic and clinical covariates.

Results

Over a 1 to 3 year follow‐up, all groups showed increased pain interference and declines in PCS and MCS scores. PCS declined by −1.01 in the OPIOID‐only group and −1.06 in the GABA‐only group. The BOTH group had stable PCS (+0.06) and a modest improvement in pain interference (−0.07). Multivariate models showed no significant difference between OPIOID‐only and GABA‐only for pain interference or PCS, but the BOTH group had significantly less pain worsening ( p = 0.0001) and PCS decline ( p = 0.004).

Conclusion

Gabapentinoids demonstrate comparable effectiveness as opioids for pain and HRQoL in cancer survivors, supporting their use as a safer alternative. Combination therapy showed better physical function and pain control, but findings may reflect higher baseline comorbidity and limited decline capacity rather than true superiority. These results underscored the need for personalized, multimodal pain management and further research on the long‐term safety of combination therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeAnalgesics, OpioidCancer SurvivorsCancer PainGabapentinChronic PainNeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultSEER Program

Stichwörter der Autor:innen

cancer survivorshipcomorbidity burdengabapentinoidshealth‐related quality of lifeopioid alternativesopioidspain interferenceprescription patterns

Substanzen

Analgesics, OpioidGabapentin

Autor:innen und Institutionen

  • John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
  • School of Public and Population Health, University of Texas Medical Branch, Galveston, Texas, USA.
  • Office of Biostatistics, Department of Biostatistics & Data Science, University of Texas Medical Branch, Galveston, Texas, USA.
  • Division of Geriatric Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
  • Department of Biostatistics & Data Science, School of Public and Population Health, University of Texas Medical Branch, Galveston, Texas, USA.

ORCID-Profile: Shirley K Chan Sanchez, Samuel V David, Efstathia Polychronopoulou, Mukaila Raji, Yong-Fang Kuo

Förderung

  • NIDA NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • National Institute on Drug Abuse

Zitieren

APA

Chan Sanchez, S. K., David, S. V., Polychronopoulou, E., Raji, M., & Kuo, Y. F. (2025). Comparative Effectiveness of Opioids and Opioid Substitutes on Pain and Health Related Quality of Life Among Cancer Survivors. Cancer Medicine. https://doi.org/10.1002/cam4.71189

Vancouver

Chan Sanchez SK, David SV, Polychronopoulou E, Raji M, Kuo YF. Comparative Effectiveness of Opioids and Opioid Substitutes on Pain and Health Related Quality of Life Among Cancer Survivors. Cancer Medicine. 2025. doi:10.1002/cam4.71189

BibTeX
@article{ChanSanchez2025,
  author = {Chan Sanchez, Shirley K and David, Samuel V and Polychronopoulou, Efstathia and Raji, Mukaila and Kuo, Yong-Fang},
  title = {Comparative Effectiveness of Opioids and Opioid Substitutes on Pain and Health Related Quality of Life Among Cancer Survivors},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71189}
}
Kostenlos starten →